migALAstat 123 MG Oral Capsule

RxCUI
2054257
RxNorm name
migALAstat 123 MG Oral Capsule
Display name
migALAstat 123 MG Oral Capsule
Full name
migALAstat 123 MG Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GalafoldMIGALASTAT HYDROCHLORIDEAmicus Therapeutics US, LLC66dbd928-0f1c-48b1-a832-54e4abd9f1db2025-08-28Adverse reactionsExact identifier
rxcui: 2054257

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
66dbd928-0f1c-48b1-a832-54e4abd9f1dbmigALAstat 123 MG Oral CapsulePSN18These highlights do not include all the information needed to use GALAFOLD safely and effectively. See full prescribing information for GALAFOLD. GALAFOLD ® (migalastat) capsules, for oral use Initial U.S. Approval: 201820250828
66dbd928-0f1c-48b1-a832-54e4abd9f1dbmigalastat 123 MG (as migalastat HCl 150 MG) Oral CapsuleSY18These highlights do not include all the information needed to use GALAFOLD safely and effectively. See full prescribing information for GALAFOLD. GALAFOLD ® (migalastat) capsules, for oral use Initial U.S. Approval: 201820250828
66dbd928-0f1c-48b1-a832-54e4abd9f1dbmigalastat 123 MG Oral CapsuleSCD18These highlights do not include all the information needed to use GALAFOLD safely and effectively. See full prescribing information for GALAFOLD. GALAFOLD ® (migalastat) capsules, for oral use Initial U.S. Approval: 201820250828